Stock ENBI ENTHEON BIOMEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Share ownership Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange
Other stock markets
 03:58:53 2024-12-06 pm EST 		5-day change 1st Jan Change
0.1750 CAD +9.38% Intraday chart for Entheon Biomedical Corp. +25.00% +75.00%
Dec. 02 Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding CI
Oct. 24 Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 CI

Major shareholders: Entheon Biomedical Corp.

NameEquities%Valuation
Canal Front Investments, Inc.
8.579 %
760,000 8.579 % 63 840 $
Timothy Ko
2.596 %
230,000 2.596 % 19 320 $
Christopher Gondi
0.5644 %
50,000 0.5644 % 4 200 $
Andrew Hegle
0.1129 %
10,000 0.1129 % 840 $

Breakdown by shareholder type

Other8.58%
Individuals3.27%
Unknown88.15%

Based on 1000 largest holdings

Geographical origin of shareholders

Canada 8.58%
Individuals 3.27%

Based on 1000 largest holdings

Company Profile

Logo Entheon Biomedical Corp.
Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.
Employees
1
Sector
Biotechnology & Medical Research
Calendar
2024-12-16 - Annual General Meeting
More about the company
  1. Stock Market
  2. Equities
  3. ENBI Stock
  4. Company Entheon Biomedical Corp.
  5. Share ownership